Eaton Vance Management Pfizer Inc Transaction History

Eaton Vance Management

$67.5 Billion
Q3 2022

A detailed history of Eaton Vance Management transactions in Pfizer Inc stock. As of the latest transaction made, Eaton Vance Management holds 7,125,127 shares of PFE stock, worth $157 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares

7,125,127

Previous 7,612,682 6.4%

Holding current value

$157 Million

Previous $399 Million 21.88%

% of portfolio

0.46%

Previous 0.56%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $21.3 Million - $26 Million	-487,555 Reduced 6.4%	7,125,127 $312 Million
Q2 2022 Aug 15, 2022	SELL	$46.53 - $55.17 $23.2 Million - $27.5 Million	-498,886 Reduced 6.15%	7,612,682 $399 Million
Q1 2022 May 16, 2022	BUY	$45.75 - $56.69 $131 Million - $162 Million	2,864,462 Added 54.59%	8,111,568 $420 Million
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $39.3 Million - $58.3 Million	951,506 Added 22.15%	5,247,106 $303 Million
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $461,972 - $593,443	11,770 Added 0.27%	4,295,600 $180 Million
Q2 2021 Aug 16, 2021	BUY	$35.91 - $40.68 $610,254 - $691,315	16,994 Added 0.4%	4,283,830 $168 Million
Q1 2021 May 17, 2021	SELL	$33.49 - $37.77 $9.48 Million - $10.7 Million	-283,001 Reduced 6.22%	4,266,836 $155 Million
Q4 2020 Feb 12, 2021	SELL	$33.47 - $42.56 $1.96 Million - $2.49 Million	-58,519 Reduced 1.27%	4,549,837 $167 Million
Q3 2020 Nov 13, 2020	SELL	$31.75 - $37.25 $5.26 Million - $6.17 Million	-165,554 Reduced 3.47%	4,608,356 $169 Million
Q2 2020 Aug 13, 2020	SELL	$30.12 - $36.54 $349,512 - $424,010	-11,604 Reduced 0.24%	4,773,910 $156 Million
Q1 2020 May 14, 2020	SELL	$27.03 - $38.62 $7.22 Million - $10.3 Million	-267,266 Reduced 5.29%	4,785,514 $156 Million
Q4 2019 Feb 11, 2020	SELL	$32.92 - $37.36 $29.8 Million - $33.8 Million	-903,933 Reduced 15.18%	5,052,780 $198 Million
Q3 2019 Nov 14, 2019	BUY	$32.49 - $42.13 $39.6 Million - $51.4 Million	1,219,189 Added 25.73%	5,956,713 $214 Million
Q2 2019 Nov 21, 2019	SELL	$36.98 - $41.52 $441,837 - $496,080	-11,948 Reduced 0.25%	4,737,524 $205 Million
Q2 2019 Aug 16, 2019	BUY	$36.98 - $41.52 $4.49 Million - $5.04 Million	121,477 Added 2.62%	4,749,472 $206 Million
Q1 2019 May 14, 2019	SELL	$37.5 - $41.2 $10.8 Million - $11.8 Million	-287,220 Reduced 5.84%	4,627,995 $197 Million
Q4 2018 Feb 07, 2019	SELL	$38.47 - $43.86 $72.8 Million - $83 Million	-1,892,132 Reduced 27.8%	4,915,215 $215 Million
Q3 2018 Nov 13, 2018	SELL	$34.47 - $41.81 $61.1 Million - $74.1 Million	-1,773,443 Reduced 20.67%	6,807,347 $300 Million
Q2 2018 Aug 10, 2018	SELL	$32.98 - $35.16 $4.99 Million - $5.32 Million	-151,450 Reduced 1.73%	8,580,790 $311 Million
Q1 2018 May 07, 2018	BUY	$31.91 - $37.02 $1.68 Million - $1.95 Million	52,787 Added 0.61%	8,732,240 $310 Million
Q4 2017 Feb 12, 2018	BUY	$33.26 - $35.29 $7.69 Million - $8.16 Million	231,247 Added 2.74%	8,679,453 $314 Million
Q3 2017 Nov 13, 2017	BUY	$31.0 - $34.15 $262 Million - $289 Million	8,448,206	8,448,206 $302 Million

Others Institutions Holding PFE

# of Institutions

3,365

Shares Held

3.56B

Call Options Held

106M

Put Options Held

123M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $124B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eaton Vance Management, based on Form 13F filings with the SEC.

News

Stay updated on Eaton Vance Management with notifications on news.

Account

Eaton Vance Management Pfizer Inc Transaction History